Sam, Mofaisa .
HRN: 19-40-14 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/02/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
03/02/2023
03/08/2023
IV
165mg
OD
Sepsis Prob Sec To Typhoid Fever; SAM
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes